Labshake search
Citations for R&D Systems :
451 - 500 of 2596 citations for Recombinant Human FCGR3B Protein His Avi tagged Biotinylated since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2021Quote: ... BMP4 recombinant protein (R&D Systems, Catalog No. 314-BP-050) was diluted in 15% pluronic gel (prepared in PBS ...
-
bioRxiv - Cell Biology 2021Quote: Recombinant proteins used are mouse FGF23 (2629-FG, R&D Systems), mouse TNFα (410-MT ...
-
bioRxiv - Cell Biology 2020Quote: Recombinant Mouse M-CSF Protein (cat# 461-ML, R&D Systems)
-
bioRxiv - Immunology 2022Quote: Recombinant Mouse IL-15R alpha Fc Chimera Protein (R&D Systems) and recombinant Mouse IL-15 (Tonbo Biosciences ...
-
bioRxiv - Developmental Biology 2023Quote: ... recombinant mNope-ECD-Fc protein (Biotechne/R&D Systems, 1294-NP) was added at 25 μg/ml (≍ 0.2 μM ...
-
bioRxiv - Bioengineering 2023Quote: ... The following recombinant target proteins were purchased from R&D Systems: CRP (1707-CR) ...
-
bioRxiv - Bioengineering 2023Quote: Recombinant SARS-CoV-2 proteins were purchased from R&D systems. For vaccination ...
-
bioRxiv - Microbiology 2023Quote: ... 200ng of recombinant ANXA2 protein (Cat# 9409-AN, R&D Systems) diluted in PBS ...
-
bioRxiv - Developmental Biology 2023Quote: ... Stock recombinant zebrafish BMP4 protein (R&D Systems 1128-BM-010) was reconstituted to 20 µg/mL in 0.1% bovine serum albumin (BSA ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant mouse IL-15Ralpha Fc chimera protein (R&D Systems), in RPMI medium (Corning Life Sciences ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... and incubated with recombinant SARS-CoV-2 Spike protein receptor binding domain (RBD) fused to the human IgG1 Fc domain (R&D Systems 10499-CV-100) or control recombinant human IgG1 Fc protein (R&D Systems 10499-CV-100 ...
-
bioRxiv - Immunology 2020Quote: ... CA) with 1% human serum and 1,200 IU/ml of recombinant human interleukin-2 (R&D Systems, Inc., Minneapolis, MN). As a positive control ...
-
bioRxiv - Pathology 2023Quote: The ROSAKIT WT human cell line (RRID:CVCL_5G49) was cultured in the presence of recombinant human SCF (80 ng/mL, R&D Systems), as described previously (23) ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... A working concentration of 1 μg/ml human ACE2 biotinylated antibody (R&D Systems, Minneapolis, MN) was prepared ...
-
bioRxiv - Immunology 2023Quote: ... the capture antibody was biotinylated polyclonal goat anti-human TREM2 (0.25 μg/mL, R&D Systems), and the detector antibody was monoclonal mouse anti-human TREM2 (1 μg/mL ...
-
bioRxiv - Neuroscience 2024Quote: ... a biotinylated polyclonal goat anti-human LGMN capture antibody (0.5 μg/ml, # BAF2199, R&D Systems), a polyclonal rabbit anti-human LGMN detection antibody (0.25 µg/ml ...
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with recombinant human IFNγ (R&D Systems, 285-IF-100) by adding an equal volume of the complete culture media containing the cytokine ...
-
bioRxiv - Neuroscience 2020Quote: ... and human recombinant FGF2 (10 ng/ml, R&D Systems, Minneapolis, Minnesota; 233-FB). After two to three weeks ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant human TGF-β (7754-BH) was purchased from R&D Systems (Minneapolis, MI). It was reconstituted at 100 μg/mL in sterile 4 mM HCl containing at least 0.1% BSA ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Developmental Biology 2020Quote: ... cells were treated with 100ng/mL human recombinant FGF4 (R&D Systems, 235-F4) in the presence of 10 μg/mL heparin sulfate and 3 μM BI-D1870 RSK inhibitor at 37°C ...
-
bioRxiv - Neuroscience 2020Quote: ... NMPM: N2B27 supplemented with 40 ng/ml recombinant human (rh) FGF2 (R&D Systems), 40 ng/ml rhFGF8 (R&D Systems) ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant pro-legumain (asparaginyl endopeptidase) was purchased from R&D Systems (2199-CY), activated per manufacturer instruction and active site titrated using MP-L01 inhibitor as described by Poreba et al ...
-
bioRxiv - Bioengineering 2019Quote: ... 0.004 % of recombinant human FGF basic (FGF-2, R&D Systems, Abingdon, United Kingdom) was added ...
-
bioRxiv - Neuroscience 2019Quote: Recombinant human IDO (Accession #P14902) was obtained from R&D Systems (#6030-AO-010) and frozen at −80°C until use ...
-
bioRxiv - Cancer Biology 2019Quote: ... Recombinant human TGFβ-1 (cat# 240B002) was purchased from R&D systems (Minneapolis, MN). Alexa 488-conjugated phalloidin (cat# A12379 ...
-
bioRxiv - Immunology 2021Quote: ... recombinant human IL-4 at 50 ng/ml (R&D Systems, Minneapolis, MN, USA) for 6 h ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant human IL-2 (50 U/mL, R&D Systems, Minneapolis, MN, USA). Single cell suspensions were activated with 1 μg/ml Concavalin A (Sigma ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Pharmacology and Toxicology 2020Quote: Recombinant human FGF23 and FGF2 were purchased from R&D Systems (Minneapolis, MN, USA). Synthetic human C-terminal FGF23 (residues 180-251 ...
-
bioRxiv - Microbiology 2019Quote: ... An isotype control (Recombinant Human IgG1 Fc, CF; R&D Systems; 110-HG-100) and recombinant rotavirus NSP4 protein were used as controls respectively ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
bioRxiv - Immunology 2022Quote: ... supplemented with 30 U/mL recombinant human IL-2 (R&D Systems #202-IL), and 55 μM beta- mercaptoethanol (Thermo # 21985023) ...
-
Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson’s diseasebioRxiv - Neuroscience 2020Quote: ... 100 ng/ml recombinant human sonic hedgehog (SHH) (R&D systems, 464-SH-025CF), 2 μM purmorphamine (Reprocell ...
-
bioRxiv - Physiology 2020Quote: ... at concentrations between 1-100 nM or recombinant human sclerostin (rhSCL) (R&D Systems) at concentrations between 1-50 ng/ml [28 ...
-
bioRxiv - Immunology 2019Quote: ... overnight before addition of 500 IU/ml recombinant human IL-2 (R&D Systems).
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Biochemistry 2020Quote: ... Recombinant human MMP-2 (902-MP-010) was purchased from R&D systems (USA). Recombinant human MMP-3 (SRP7783 ...
-
bioRxiv - Biochemistry 2021Quote: ... Treatments with human recombinant 10 ng/ml TGF-β1 (R&D Systems, Minneapolis, MN) were performed after serum-free starvation for 12 hours (h).
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Developmental Biology 2021Quote: ... were embedded in a Bmp7 solution (R&D systems, Recombinant Human BMP7 #354-BP) in PBS ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant human TGFβ and Universal Type I IFN was obtained from R&D Systems.
-
Immunoresolvents Support Skeletal Myofiber Regeneration via Actions on Myeloid and Muscle Stem CellsbioRxiv - Immunology 2020Quote: ... and human recombinant GM-CSF (20 ng/mL) (R&D Systems, 215-GM-010). Cells then were washed with PBS to remove non-adherent cells and detached by incubation in TrypLE Select at 37°C followed by gentle cell scraping ...
-
bioRxiv - Immunology 2022Quote: ... and 25 ng/mL human recombinant M-CSF (#216-MC, R&D Systems Inc). Cells were differentiated for 7-10 days prior to treatment as has previously been shown to yield mature macrophages (44) ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were stimulated with 50 ng/ml recombinant human BMP-9 (R&D Systems) and 150 ng/ml recombinant human VEGF (PeproTech ...
-
bioRxiv - Bioengineering 2022Quote: ... or 150 ng/ml recombinant human LOX homolog like 2 (LOXL2, R&D Systems), with media changed every 2-3 days ...
-
bioRxiv - Cell Biology 2022Quote: ... the samples were treated with human recombinant LOXL3 (RhLOXL3, R&D systems, 6069-AO) or LOXL2 (RhLOXL2 ...
-
bioRxiv - Immunology 2022Quote: ... 200 IU/ml of recombinant human IL-2 (R&D Systems, 202-IL-050) and expanded for 10 – 14 days ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems, Minneapolis, MN), recombinant human interleukin 4 (IL-4 ...